FDA+ channel feed – Endpoints News

FDA+ channel feed

Pandemic wait is over: FDA begins transition to in-person meetings in March

3 years ago

Covid public health emergencies to end in May, but FDA's EUA authority will continue

3 years ago

Oracle executive Troy Tazbaz named new FDA director of digital health

3 years ago

FDA approves Italy-based pharma's oral SERD for some breast cancer patients

3 years ago

Novavax gets ready to take another shot at Covid vaccine market with next season plans

3 years ago

Post-hoc analysis: EMA's CHMP rejects Ipsen's potential drug for rare genetic disease

3 years ago

FDA approves another indication for Keytruda, this time in the adjuvant NSCLC setting

3 years ago

Four years in, Sana gets first FDA go-ahead to bring cancer treatment into the clinic

3 years ago

FDA advisory committee votes unanimously in favor of bivalent Covid shots replacing primary series

3 years ago

FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study

3 years ago

FDA cuts off use for AstraZeneca’s Covid-19 therapy Evusheld

3 years ago

FDA takes next step in Torrent Pharmaceuticals' troubled India plant saga, issues OAI

3 years ago

FDA sends warning letter to community hospital review board over research concerns

3 years ago

EMA changes orphan designation policy for certain eye drugs to expand access

3 years ago

ODAC to debate Roche's Polivy in first-line DLBCL following 2019 accelerated approval

3 years ago

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

3 years ago

Advocacy group accuses Novo Nordisk of violating FDA's 'fair balance' advertising rules

3 years ago

FDA lays the finishing touches on its plan to pull Makena

3 years ago

On orphan drug exclusivity, FDA decides to go its own way after court loss

3 years ago

FDA will consult outside advisors on whether Biogen’s ALS drug can be approved on a biomarker

3 years ago

FDA hopes to simplify and standardize Covid shots without making them interchangeable

3 years ago

Next-gen mpox treatments: FDA calls for diverse, randomized controlled trials

3 years ago

'Blue Brain Boost': FDA blocks Colorado couple from importing and reselling drugs from China

3 years ago

FDA lifts clinical hold on Astellas’ Pompe gene therapy

3 years ago

First page Previous page 61 62 636465 66 67 Next page Last page